Box score
Interpace Biosciences, Inc.
Reported $47M sold in a new Form D filed October 16, 2024 (Parsippany, New Jersey).
- Biggest raise
- $47M filed Oct 16, 2024
- League
- Bio & Health Other Health Care
- Based in
- Parsippany, New Jersey
- Season rank
- #114 of 1,389 in the Bio & Health League; #429 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-10-16 | New notice | $47M | $47M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1054102.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Outlook Therapeutics, Inc. | Bio & Health | $60M |
| 2 | Navigator Medicines, Inc. rookie | Bio & Health | $50M |
| 3 | ChemoMouthpiece, LLC rookie | Bio & Health | $10M |
| 4 | Imunon, Inc. | Bio & Health | $10M |
| 5 | Neurock Pharmaceuticals Inc. rookie | Bio & Health | $10M |
| 6 | Claris Biotherapeutics, Inc. | Bio & Health | $10M |